Market Snapshot

BSE Sensex: 83576.24 -0.72%
BSE 500: 36807.62 -0.89%
BSE 200: 11620.53 -0.79%
BSE 100: 26904.82 -0.73%
BSE MidCap: 46304.8 -0.90%
BSE SmallCap: 49912.11 -1.74%
BSE BANKEX: 66616.92 -0.58%
BSE IT: 36795.24 0.03%
Nifty 50: 25683.3 -0.75%
Nifty 500: 23467.35 -0.90%
Nifty 200: 14306.95 -0.79%
Nifty 100: 26252.95 -0.79%
Nifty Midcap 100: 59748.15 -0.79%
Nifty Small 100: 17282.65 -1.81%
Nifty IT: 38027.2 0.28%
Nifty PSU Bank: 8601.05 0.18%

News:

Protean eGov Technologies bags...
PTC Industries? arm secures ma...
Globus Spirits reports multi-f...
IREDA Q3 PAT jumps 15% YoY to ...
Tejas Networks reports dismal ...

Dr Lal Pathlabs Ltd Share Price – NSE / BSE
Healthcare, Small Cap

Invest

09 Jan 2026 | 03:59 PM

1,417.00

-34.40 (-2.37%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-5.75%

Return (1Y)

Underperformed BSE Healthcare by 3.29%
More Volatile

1.75%

Standard Deviation (1Y)

Higher than BSE Healthcare by 0.78%
Inconsistent Performer

3/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

1,771

1,148

News & Announcements

Dr Lal Pathlabs launches 'Sovaaka' new-age diagnostic centre in Gurugram
5 days ago

Dr Lal Pathlabs launches 'Sovaaka' new-age diagnostic centre in Gurugram

06 - Jan - 2026 12:00 | 5 days ago

Dr Lal PathLabs announced the launch of Sovaaka, its new-age Diagnostic Experience Centre in Gurugram.

Built on the philosophy of ?Science Behind Wellness,? Sovaaka introduces a new standard in preventive and lifestyle healthcare. As an advanced wellness initiative from the house of Dr. Lal PathLabs, the centre brings together precision diagnostics, cutting-edge technology, and medical expertise to help individuals take proactive control of their health.

Sovaaka offers a deeply personalised diagnostics-led wellness experience that goes beyond routine health checks. Its doctor-designed programs ? including Eterna (for women) and Vita (for men) ? are customised to an individual's age, gender, and lifestyle. It brings together advanced diagnostics such as high-sensitivity blood panels, genetic testing, AI-supported imaging, and seamlessly integrated digital health records. With end-to-end clinical report evaluation and tailored nutrition guidance, Sovaaka delivers a truly comprehensive, understanding of one's health and wellness trajectory.

The launch comes at a time when India is witnessing rapid growth in the preventive health and wellness segment, driven by increasing incidence of Non-Communicable Diseases, rising awareness, evolving lifestyles, and greater emphasis on early detection. With Sovaaka, Dr. Lal PathLabs takes a significant step forward in strengthening preventive care by offering comprehensive, evidence-backed solutions that empower individuals to understand their health better and act early.
Powered by Capital Market - Live News
Dr. Lal PathLabs announces board meeting date
13 days ago

Dr. Lal PathLabs announces board meeting date

29 - Dec - 2025 12:00 | 13 days ago

Dr. Lal PathLabs will hold a meeting of the Board of Directors of the Company on 30 January 2026.
Powered by Capital Market - Live News
Dr Lal Pathlabs approves bonus issue of 1:1
72 days ago

Dr Lal Pathlabs approves bonus issue of 1:1

31 - Oct - 2025 12:00 | 72 days ago

The board of Dr Lal Pathlabs at its meeting held on 31 October 2025 has approved bonus issue of 1:1.
Powered by Capital Market - Live News
Dr Lal Pathlabs fixes record date for 2nd interim dividend
72 days ago

Dr Lal Pathlabs fixes record date for 2nd interim dividend

31 - Oct - 2025 12:00 | 72 days ago

Dr Lal Pathlabs has fixed 07 November 2025 as record date for purpose of 2nd interim dividend of Rs 7 per equity share for FY 2025-26.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Dr Lal Pathlabs Ltd has given the 3rd best dividend yield 0.61 for 3 Year among stocks in Healthcare Sector
Dr Lal Pathlabs Ltd has given the 2nd best dividend yield 0.72 for 1 Year among stocks in Healthcare Sector
FII shareholding in Dr Lal Pathlabs Ltd has decreased by -5.41% since past 3 Months
MF shareholding in Dr Lal Pathlabs Ltd has increased by 4.4% since past 3 Months

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

General Notifications

My Notifications

Research Notifications

Dr Lal Pathlabs Ltd Share Price – NSE / BSE Healthcare, Small Cap

1,417.00 -34.40 (-2.37%)

News & Announcements

Price vs Volume

Stock Trivia

Dr Lal Pathlabs Ltd Share Price – NSE / BSE
Healthcare, Small Cap

1,417.00

-34.40 (-2.37%)